Physical Activity, Fatigue, Social Support, and Psychological Well-Being in Women With Primary Hypothyroidism

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorUniversity of Oviedo

About this trial

Background. Primary hypothyroidism, both clinical and subclinical, is frequently associated with persistent fatigue, reduced psychological well-being, and lower levels of physical activity in adult women. However, evidence integrating these psychosocial factors remains limited and methodologically heterogeneous.

Objective. To analyze the association between physical activity and fatigue, social support, and psychological well-being in women with primary hypothyroidism; to compare these profiles between clinical and subclinical hypothyroidism; and to explore the moderating effect of social support and psychological well-being on the relationship between fatigue and physical activity.

Methods. An observational, analytical, multicenter cohort study will be conducted including 96 adult women with primary hypothyroidism from the Principality of Asturias. Physical activity levels will be assessed using the International Physical Activity Questionnaire-Short Form (IPAQ-SF), while fatigue, social support, and psychological well-being will be measured using the Fatigue Severity Scale (FSS), the Medical Outcomes Study Social Support Survey (MOS-SSS), and the WHO-5 Well-Being Index, respectively. Confounding variables will include age, body mass index, type of hypothyroidism (clinical or subclinical), and time since diagnosis. Descriptive analyses, comparisons between clinical and subclinical groups, and multiple linear regression models will be performed.

Expected results. The study is expected to identify physical activity levels within the sample and determine which psychosocial factors are independently associated with physical activity. Additionally, fatigue is anticipated to be negatively associated with physical activity, whereas social support and psychological well-being are expected to show positive associations and potential moderating effects.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Have a diagnosis of primary hypothyroidism (clinical or subclinical), established by a specialist in Endocrinology or Internal Medicine based on TSH and FT4 levels.

Female.

Are aged ≥18 years at the time of inclusion.

Have stable treatment for thyroid dysfunction (levothyroxine dose or other replacement regimen without relevant modifications) for at least the previous 3 months, or a stable clinical condition if treatment is not required.

Disqualifiers

Have a diagnosis of severe medical conditions that predominantly limit the ability to perform physical activity independently of hypothyroidism (e.g., advanced heart failure, severe chronic respiratory disease).

Have severe psychiatric disorders or significant cognitive impairment that hinder understanding of the information or reliable completion of the questionnaires.

Have undergone major surgery, severe trauma, or an acute medical condition that has substantially limited physical activity in the three months prior to assessment.

Are pregnant or in the immediate postpartum period, due to potential hormonal and functional interference with the study variables.

Trial population

Women with primary hypothyroidism

Trial design

Design model

Cohort

Time perspective

Cross-sectional

Treatments tested in this trial

  • Women with primary hypothyroidism sample

    Other intervention

    To assess the level of physical activity in women with primary hypothyroidism and to identify the predictive model of physical activity in this population.

Treatment groups

96 Participants
are divided into 1 treatment group
Group A: Observational group1 intervention

Trial outcomes

Primary outcomes

1

Measurement of habitual physical activity level

This variable will be assessed using the Spanish version of the International Physical Activity Questionnaire-Short Form (IPAQ-SF). This instrument, widely used in clinical and population-based research, allows estimation of weekly energy expenditure in MET-minutes and classification of participants into low, moderate, or high physical activity categories.

Time frame
Screening visit

Secondary outcomes

1

Measurement of perceived fatigue

This variable will be assessed using the Spanish-validated Fatigue Severity Scale (FSS). The FSS is one of the most widely used instruments internationally to measure physical and mental fatigue in chronic conditions and consists of nine items rated on a 1-7 scale.

Time frame
Screening visit
2

Measurement of perceived social support

This variable will be assessed using the Spanish version of the Medical Outcomes Study Social Support Survey (MOS-SSS). This 19-item questionnaire evaluates four dimensions of support (emotional/informational, instrumental, affectionate, and positive social interaction).

Time frame
Screening visit
3

Measurement of psychological well-being

This variable will be assessed using the Spanish version of the WHO-5 Well-Being Index. This five-item instrument evaluates subjective well-being over the previous two weeks and its use in research is recommended by the World Health Organization.

Time frame
Screening visit

Other outcomes

1

Measurement of age

This potential confounding or moderating variable, which may influence the relationship between physical activity and psychosocial factors, will be assessed in years.

Time frame
Screening visit
2

Measurement of body mass index

This potential confounding or moderating variable, which may influence the relationship between physical activity and psychosocial factors, will be calculated from body mass and height (kg/m²).

Time frame
Screening visit
3

Measurement of type of hypothyroidism

This potential confounding or moderating variable, which may influence the relationship between physical activity and psychosocial factors, will be classified as clinical or subclinical primary hypothyroidism based on TSH and FT4 levels.

Time frame
Screening visit
4

Measurement of time since diagnosis

This potential confounding or moderating variable, which may influence the relationship between physical activity and psychosocial factors, will be assessed in years.

Time frame
Screening visit

Sponsors and contacts

Click on the lead sponsor to view all of their trials.